Conference Committees

IPVC 2025 Co-Chairs

Anna R. Giuliano

USA

Anna R. Giuliano, PhD, is the founding director of the Center for Immunization and Infection Research in Cancer (CIIRC) at the Moffitt Cancer Center in Tampa, Florida. Dr Giuliano’s career had its inception in the relationship between human papillomavirus (HPV) infections and cervical cancer, and has evolved over the past 30 years to encompass penile, anal, and oral cancers in men, as well as other infectious diseases and their causal relationships with various cancers. Her work has contributed significantly to our understanding of HPV natural history and to HPV vaccine protection against multiple diseases in women and men.
An expert in the field of cancer research she has led numerous studies conducted globally. Dr Giuliano was a contributor to the 1999 Institute of Medicine (IOM) report titled The Unequal Burden of Cancer and the 2005 International Agency for Research on Cancer (IARC) report that concluded for the first time that HPV is a cause of multiple cancers in women and men. In 2013, at the American Cancer Society (ACS) 100th anniversary, she was the recipient of the ACS Distinguished Achievement in Cancer Award. In 2018, she was selected for the ACS Clinical Research Professor Award for “Prevention of Infection-Related Cancers.” In 2019, Dr. Giuliano received the American Society of Preventive Oncology (ASPO) Fraumeni Distinguished Lifetime Achievement Award.
Dr Giuliano has authored >400 peer-reviewed publications.

Siriwan Tangjitgamol

Thailand

IPVC 2025 Program Organizing Committee

Aimee Kreimer

POC Chair

Dr. Kreimer is a Senior Investigator at the US National Cancer Institute, Division of Cancer Epidemiology and Genetics. She focuses her research on the etiology and prevention of human papillomavirus (HPV) and cancers at multiple sites, including the head and neck and anogenital region. She has particular interests in translational research, cancer etiology related to the natural history of HPV infection at multiple anatomic sites, and cancer prevention. She leads investigations on associations between HPV serostatus and risk of HPV-driven oropharyngeal cancers. She is the Principal Investigator on several prophylactic HPV vaccine trials including “ESCUDDO: A Randomized Trial of One-Dose HPV Vaccination,” a research initiative of the Cancer Moonshot.

Anna R. Giuliano

IPVC Chair

Suzanne Garland

Interdisciplinary Chair

Department of Microbiology and Infectious Diseases, Royal Women’s Hospital, Department of Microbiology, RCH Honorary Research Fellow, Murdoch Childrens Research Institute Department of Obstetrics and Gynaecology, The University of Melbourne, Melbourne, Australia

Anna-Barbara Moscicki

Clinical Science Chair

Ann Burchell

Public Health Chair

Dr. Ann Burchell, Canada Research Chair in Sexually Transmitted Infection Prevention, uses epidemiological data to improve prevention and health care for HPV, HIV, and other STIs and minimize the complications associated with these diseases. She and her research team hope to promote sexual health for all by supporting effective and practical strategies to prevent STIs and related cancers in high-risk populations. Dr. Burchell is a scientist with MAP Centre for Urban Health Solutions in the Li Ka Shing Knowledge Institute of St. Michael’s Hospital, and Research Director of St. Michael’s Department of Family and Community Medicine. She is also a scientist with ICES, an Associate Professor in the University of Toronto’s Faculty of Medicine (Department of Family and Community Medicine) and Dalla Lana School of Public Health (Division of Epidemiology).

Karl Munger

Basic Science Chair

Basic Science Committee

Karl Munger

Basic Science Chair

Clinical Science Committee

Anna-Barbara Moscicki

Clinical Science Chair

Richard Hillman

Australia

Kimon Chatzistamatiou

Greece

Dr Kimon Chatzistamatiou is an academic consultant in the 1st Department of Obstetrics and Gynecology at the Aristotle University of Thessaloniki, Greece. He received his MD (2002) and PhD (2017) from the Medical School of the Aristotle University of Thessaloniki. He is board-certified in Obstetrics and Gynecology (2013), certified in colposcopy and cervical pathology (2014), and has overseen the lower genital tract clinic at “Papageorgiou” General Hospital in Thessaloniki, Greece, since 2018.

Siriwan Tangjitgamol

Thailand

Patravoot Vatanasapt

Thailand

Public Health, Epidemiology & Implementation Science Committee

Ann Burchell

Public HealthChair

Tim Waterboer

Germany

Annette Sohn

Thailand

Nittaya Phanuphak

Thailand

Awareness Committee

Joel Palefsky

Chair

M.D., C.M., F.R.C.P.(C). Professor of Medicine at the University of California San Francisco School of Medicine. His interests include the molecular biology, treatment, pathogenesis and natural history of anogenital human papillomavirus infections, particularly in the setting of HIV infection. He is the director of the world's first clinic devoted to prevention of anal cancer, the Anal Neoplasia Clinic Research and Education Center at the UCSF Cancer Center. He is the chair of the Anal Cancer /HSIL Outcomes Research (ANCHOR) Study, a national multi-site NIH study designed to determine whether treatment of anal cancer precursor lesions prevents the development of anal cancer. He is the founder and past president of the International Anal Neoplasia Society and is the past president of the International Papillomavirus Society (IPVS). He continues to serve on the board of IPVS and leads the IPVS International HPV Awareness Day Campaign.

Interdisciplinary Committee

Suzzane Garland

Interdisciplinary Chair

Prof. Reproductive & Neonatal Infectious Diseases, Department of Obstetrics and Gynaecology, University of Melbourne, Director Centre Women’s Infectious Diseases Research, Royal Women’s Hospital and Honorary Research Fellow, Infection & Immunity, Murdoch Children’s Research Institute.

Early Career Researcher (ECR) Committee

Staci Sudenga

ECR Chair

Dr. Staci Sudenga is an Assistant Professor of Medicine in the Division of Epidemiology at Vanderbilt University Medical Center. Dr. Sudenga’s research focuses on infections and cancer, the natural history of infections, and the synergy between infections. Her goal as a molecular epidemiologist is to conduct research in clinical cohort studies in order to identify biomarkers that increase the risk for cancer that can be translated into primary prevention efforts, early diagnosis, or treatment. Dr. Sudenga has several funded projects focused on early detection and biomarkers related to anal cancer.